CMI’nov expands its leadership team with the appointment of Laure Oliver as Director Regulatory Affairs.

Monistrol sur Loire, May 31, 2020

CMI’nov today announced that Laure Oliver will join its leadership team as Regulatory Affairs and Assurance quality director, effective June 1st, 2020. She will be responsible for all regulatory aspects of the preclinical and clinical program.

Bernard Pain commented: “Laure brings tremendous experience and leadership in the regulatory path to market for medical devices. She has over 20 years of international experience in medical devices, including class III devices.” 

Laure Oliver said: « I am very happy to join the leadership team and delighted to contribute to the development of Mit’rep, particularly under the new European regulatory framework, 2017/745. The challenge is in line with the benefits that the product is expected to bring to patients.” 

Mit’rep is a new generation minimally invasive annuloplasty device for the treatment of functional mitral regurgitation. Nitinol anchors delivered transapically are used to position a braid along the mitral ring, which is then used to reduce the mitral valve diameter at will, in real-time under echography.

For additional information, please contact Corinne.pain@cmi-nov.com